These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 3088114

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR, Hoyer M, Leyko MA, Horvat R, Parmely M, Whitacre C, Zwilling B, Rinehart JJ.
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [Abstract] [Full Text] [Related]

  • 4. Modulation of monocyte complement synthesis by lymphocytes and lymphocyte-conditioned media.
    Lappin D, Whaley K.
    Clin Exp Immunol; 1989 Apr; 76(1):86-91. PubMed ID: 2500276
    [Abstract] [Full Text] [Related]

  • 5. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
    Kleinerman ES, Zicht R, Sarin PS, Gallo RC, Fidler IJ.
    Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
    Schreiber RD, Hicks LJ, Celada A, Buchmeier NA, Gray PW.
    J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
    [Abstract] [Full Text] [Related]

  • 7. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
    Lee JC, Rebar L, Young P, Ruscetti FW, Hanna N, Poste G.
    J Immunol; 1986 Feb 15; 136(4):1322-8. PubMed ID: 3003193
    [Abstract] [Full Text] [Related]

  • 8. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J.
    J Immunol; 1983 Dec 15; 131(6):2821-6. PubMed ID: 6417232
    [Abstract] [Full Text] [Related]

  • 9. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
    Murray HW, Spitalny GL, Nathan CF.
    J Immunol; 1985 Mar 15; 134(3):1619-22. PubMed ID: 3918107
    [Abstract] [Full Text] [Related]

  • 10. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
    Nacy CA, Fortier AH, Meltzer MS, Buchmeier NA, Schreiber RD.
    J Immunol; 1985 Nov 15; 135(5):3505-11. PubMed ID: 3930606
    [Abstract] [Full Text] [Related]

  • 11. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937.
    Harris PE, Ralph P, Litcofsky P, Moore MA.
    Cancer Res; 1985 Jan 15; 45(1):9-13. PubMed ID: 2981161
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T, Sone S.
    J Immunol; 1986 Feb 01; 136(3):1117-22. PubMed ID: 3079797
    [Abstract] [Full Text] [Related]

  • 13. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
    Platzer E, Rubin BY, Lu L, Welte K, Broxmeyer HE, Moore MA.
    J Immunol; 1985 Jan 01; 134(1):265-71. PubMed ID: 3917276
    [Abstract] [Full Text] [Related]

  • 14. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
    Murray HW, Rubin BY, Carriero S, Acosta AM.
    J Immunol; 1984 Oct 01; 133(4):2250-4. PubMed ID: 6432909
    [Abstract] [Full Text] [Related]

  • 15. Effects of vitamin D3 and IFN-gamma on the synthesis of the second complement component, C2, by a human myeloid leukemia (HL-60) cell line.
    Littman BH, Sanders KM.
    J Immunol; 1988 May 01; 140(9):3082-5. PubMed ID: 2834451
    [Abstract] [Full Text] [Related]

  • 16. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
    Hancock WW, Muller WA, Cotran RS.
    J Immunol; 1987 Jan 01; 138(1):185-91. PubMed ID: 3097144
    [Abstract] [Full Text] [Related]

  • 17. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
    Talmadge KW, Gallati H, Sinigaglia F, Walz A, Garotta G.
    Eur J Immunol; 1986 Dec 01; 16(12):1471-7. PubMed ID: 3102242
    [Abstract] [Full Text] [Related]

  • 18. Interferon gamma: more than a MAF.
    Peters PM, Svedersky LP, Shalaby MR, Palladino MA.
    Lymphokine Res; 1985 Dec 01; 4(3):265-73. PubMed ID: 3928982
    [Abstract] [Full Text] [Related]

  • 19. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
    Murray HW, Gellene RA, Libby DM, Rothermel CD, Rubin BY.
    J Immunol; 1985 Oct 01; 135(4):2374-7. PubMed ID: 3928746
    [Abstract] [Full Text] [Related]

  • 20. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A, Gray PW, Rinderknecht E, Schreiber RD.
    J Exp Med; 1984 Jul 01; 160(1):55-74. PubMed ID: 6330272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.